Anne-Laure Humbert1, Guillaume Lecoanet2, Sophie Moog1, Fehd Bouderraoui3, Laurent Bresler4, Jean-Michel Vignaud5, Elodie Chevalier3, Laurent Brunaud4, Marc Klein1, Thomas Cuny6. 1. Department of Endocrinology, University Hospital of Nancy, Nancy, France. 2. Department of Radiology, University Hospital of Nancy, Nancy, France. 3. Department of Nuclear Medicine, University Hospital of Nancy, Nancy, France. 4. Department of Endocrine and General Surgery, University Hospital of Nancy, Nancy, France. 5. Department of Anatomopathology, University Hospital of Nancy, Nancy, France. 6. Department of Endocrinology, University Hospital of Nancy, Nancy, France. thomascuny@hotmail.com.
Abstract
PURPOSE: Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score. METHODS: Seventy five patients operated between 2004 and 2016 in the University Hospital of Nancy for either adrenocortical carcinomas (ACC) or adrenocortical adenomas (ACA) were enrolled in this study. We collected cortisol parameters, Computed Tomography (CT) scans (unenhanced density, wash-out (WO) analysis) and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) datas. The histopathological Weiss score ultimately differentiates ACA (score ≤ 2) from ACC (score ≥ 3). One-way ANOVA, Fisher's exact and unpaired t tests were used for statistical analysis with significancy reached at p < 0.05. RESULTS: There were 23 ACC and 52 ACA with 40 patients (53%) who had an autonomous secretion of cortisol. On CT scan, ACC were larger compared to ACA (108 vs. 37 mm, p < 0.0001). A roughly similar proportion of cortisol-secreting (22/25) and non-secreting (15/19) ACA were atypical (i.e., unenhanced density value ≥ 10 Hounsfield Units [HU]), however 85% of cortisol-secreting vs. 40% of non-secreting ACA were classified as benigns by the relative WO analysis (p = 0.08). Likewise, there was a trend for a higher 18F-FDG uptake in cortisol-secreting ACA compared to non-secreting ACA (p = 0.053). CONCLUSIONS: The relative adrenal WO analysis consolidates the benign nature of an ACA, especially in case of cortisol oversecretion, a condition known to compromise the diagnostic accuracy of the 10 HU unenhanced CT attenuation threshold.
PURPOSE:Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score. METHODS: Seventy five patients operated between 2004 and 2016 in the University Hospital of Nancy for either adrenocortical carcinomas (ACC) or adrenocortical adenomas (ACA) were enrolled in this study. We collected cortisol parameters, Computed Tomography (CT) scans (unenhanced density, wash-out (WO) analysis) and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) datas. The histopathological Weiss score ultimately differentiates ACA (score ≤ 2) from ACC (score ≥ 3). One-way ANOVA, Fisher's exact and unpaired t tests were used for statistical analysis with significancy reached at p < 0.05. RESULTS: There were 23 ACC and 52 ACA with 40 patients (53%) who had an autonomous secretion of cortisol. On CT scan, ACC were larger compared to ACA (108 vs. 37 mm, p < 0.0001). A roughly similar proportion of cortisol-secreting (22/25) and non-secreting (15/19) ACA were atypical (i.e., unenhanced density value ≥ 10 Hounsfield Units [HU]), however 85% of cortisol-secreting vs. 40% of non-secreting ACA were classified as benigns by the relative WO analysis (p = 0.08). Likewise, there was a trend for a higher 18F-FDG uptake in cortisol-secreting ACA compared to non-secreting ACA (p = 0.053). CONCLUSIONS: The relative adrenal WO analysis consolidates the benign nature of an ACA, especially in case of cortisol oversecretion, a condition known to compromise the diagnostic accuracy of the 10 HU unenhanced CT attenuation threshold.
Authors: Andrea Frilling; Karsten Tecklenborg; Frank Weber; Hilmar Kühl; Stephan Müller; Georgios Stamatis; Christoph Broelsch Journal: Surgery Date: 2004-12 Impact factor: 3.982
Authors: M Korobkin; T J Giordano; F J Brodeur; I R Francis; E S Siegelman; L E Quint; N R Dunnick; J P Heiken; H H Wang Journal: Radiology Date: 1996-09 Impact factor: 11.105
Authors: Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio Journal: N Engl J Med Date: 2014-02-26 Impact factor: 91.245
Authors: Julie H Song; David J Grand; Michael D Beland; Kevin J Chang; Jason T Machan; William W Mayo-Smith Journal: AJR Am J Roentgenol Date: 2013-12 Impact factor: 3.959
Authors: T M A Kerkhofs; M H T Ettaieb; R H A Verhoeven; G J L Kaspers; W J E Tissing; J Loeffen; M M Van den Heuvel-Eibrink; R R De Krijger; H R Haak Journal: Oncol Rep Date: 2014-09-22 Impact factor: 3.906